Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer.
Takeuchi E, Kondo K, Okano Y, Kunishige M, Kondo Y, Kadota N, Machida H, Hatakeyama N, Naruse K, Ogino H, Nokihara H, Shinohara T, Nishioka Y.
Takeuchi E, et al. Among authors: kadota n.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3139-3147. doi: 10.1007/s00432-022-04215-7. Epub 2022 Jul 24.
J Cancer Res Clin Oncol. 2023.
PMID: 35871700
Free PMC article.